ITGB1 and neoplasm: Ki67 expression in tumors was determined by immunohistochemistry, and the proportion of Ki67-positive cells in tumors was decreased in tumor-bearing mice established by OCSCC cells with BMI1 or ITGB1 knockdown (Fig. 5B).